[VYNE] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
05-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 85.24%
YoY- -46.63%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 4,258 4,119 4,286 3,269 11,688 1,750 0 -
PBT -19,924 -20,550 -23,181 -24,713 -167,699 -40,233 -21,498 -4.94%
Tax 1,005 1,005 -258 1 -259 728 -52,379 -
NP -19,924 -20,550 -23,181 -24,714 -167,440 -40,233 -21,498 -4.94%
Tax Rate - - - - - - - -
Total Cost 24,182 24,669 27,467 27,983 179,128 41,983 21,498 8.16%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -467.92 -498.91 -540.85 -756.01 -1,432.58 -2,299.03 0.00 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -6.98 -7.57 -8.54 -10.61 -86.95 -68.15 -64.36 -77.28%
EPS Diluted -6.98 -7.57 -8.54 -10.61 -86.95 -68.15 -64.36 -77.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.